Bin Xia Yang

With a deep expertise in biotechnology and therapeutic development, I specialize in building and scaling innovative therapeutics. My work spans the entire therapeutic development lifecycle—from scientific discovery and IND enabling studies to clinical execution and regulatory strategy. As a therapeutic developer, I have led the advancement of novel treatments, optimizing drug pipelines and navigating complex clinical landscapes. In portfolio management, I strategically assess and prioritize high-impact assets, ensuring alignment with market needs and investment opportunities. My experience extends across global markets, where I drive cross-border regulatory and development strategies for siRNA, ASO and biologic therapies. Passionate about accelerating the future of medicine, I thrive at the intersection of science, technology, business, and strategy, shaping the next generation of transformative therapeutics. I hold an MD and PhD with 10+ years of research experience prior joining the industry. my expertise includes hiPSC generation, hiPSC-derived disease modelling and hiPCS-derived cell-therapies. I have published 10+ scientific articles in top-tier journals, including Cell, Stem Cells, Nature Communication, PNAS and Stem Cell Translational Medicine etc.